Correlation Between Precipio and BioMark Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Precipio and BioMark Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precipio and BioMark Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precipio and BioMark Diagnostics, you can compare the effects of market volatilities on Precipio and BioMark Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precipio with a short position of BioMark Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precipio and BioMark Diagnostics.

Diversification Opportunities for Precipio and BioMark Diagnostics

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Precipio and BioMark is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Precipio and BioMark Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioMark Diagnostics and Precipio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precipio are associated (or correlated) with BioMark Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioMark Diagnostics has no effect on the direction of Precipio i.e., Precipio and BioMark Diagnostics go up and down completely randomly.

Pair Corralation between Precipio and BioMark Diagnostics

Given the investment horizon of 90 days Precipio is expected to generate 1.07 times more return on investment than BioMark Diagnostics. However, Precipio is 1.07 times more volatile than BioMark Diagnostics. It trades about 0.01 of its potential returns per unit of risk. BioMark Diagnostics is currently generating about 0.01 per unit of risk. If you would invest  600.00  in Precipio on September 12, 2024 and sell it today you would earn a total of  0.00  from holding Precipio or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Precipio  vs.  BioMark Diagnostics

 Performance 
       Timeline  
Precipio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Precipio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Precipio is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
BioMark Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioMark Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Precipio and BioMark Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Precipio and BioMark Diagnostics

The main advantage of trading using opposite Precipio and BioMark Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precipio position performs unexpectedly, BioMark Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioMark Diagnostics will offset losses from the drop in BioMark Diagnostics' long position.
The idea behind Precipio and BioMark Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format